Why a Clinical Trial?
“Double the number of lung cancer patients participating in clinical trials: The Partnership will help patients understand the importance of participating in clinical trials, which can lead to new cutting-edge therapies and treatments, as well as work with physicians to ensure greater participation among their patients. The Partnership will substantially increase the number of lung cancer patients who participate in clinical trials annually from less than one percent of eligible patients to 5 percent”. Free to Breathe -Lung Cancer Partnership
No comments:
Post a Comment